The incidence of differentiated thyroid cancer is rising at the second fastest rate of all malignancies in the United States, making it an increasingly important public health problem. While patients with early stage thyroid cancer are usually successfully treated, the survival rate for patients with distant metastatic or nvasive disease is approximately 40% at 5 years. The pathways responsible for thyroid cancer progression are not clear. We have observed that the invasive fronts of aggressive thyroid cancers display an epithelial to mesenchymal transition (EMT)-like gene expression profile that differs from the central regions of the tumors. The association between EMT and thyroid cancer invasion was further demonstrated in a larger validation series in which overexpression of vimentin was independently associated with tumor invasiveness. The overexpression of mesenchymal proteins occurred in invasive PTCs that expressed BRAF V600E or RET/PTC oncogenes. In vitro studies demonstrated the requirement of vimentin expression for thyroid cancer migration and for the development of a mesenchymal phenotype in thyroid cancer cells. p21- activated kinases (PAKs) are master regulators of actin rearrangement and cell polarity and motility that are downstream of PDK1 and other pathways activated in thyroid cancer. Enhanced expression of PAK regulators and effectors was noted in the expression arrays and increased levels of total and phosphorylated PAK were identified in primary thyroid cancers. Subsequent in vitro data support an association between PAK activity and expression and function of RET/PTC and BRAF V600E oncogenes, and a role for PAK in thyroid cancer motility. Because our goal is to target invasive or progressive thyroid cancers, we also tested OSU-03012, a novel kinase inhibitor that competes with targets involved in EMT in vitro. The goal of this proposal is to define the role and upstream regulation of PAK in thyroid cancer EMT;determine the downstream mechanism for PAK-regulated EMT focused on pathways identified in our preliminary studies; and to determine if OSU-03012 influences thyroid cancer cell development and progression in vivo.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA124570-04
Application #
8234145
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-03-01
Budget End
2012-02-29
Support Year
4
Fiscal Year
2011
Total Cost
$268,905
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Yu, Wanfeng; Ni, Ying; Saji, Motoyasu et al. (2017) Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells. Hum Mol Genet 26:1365-1375
Gudmundsson, Julius; Thorleifsson, Gudmar; Sigurdsson, Jon K et al. (2017) A genome-wide association study yields five novel thyroid cancer risk loci. Nat Commun 8:14517
Azmat, Umal; Porter, Kyle; Senter, Leigha et al. (2017) Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies. Thyroid 27:74-80
Chen, Hannah H; Händel, Norman; Ngeow, Joanne et al. (2017) Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol 139:607-620.e15
Rossfeld, Kara K; Justiniano, Steven E; Ding, Haiming et al. (2017) Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model. J Clin Endocrinol Metab 102:3268-3277
Saporito, Donika; Brock, Pamela; Hampel, Heather et al. (2017) Penetrance of a rare familial mutation predisposing to papillary thyroid cancer. Fam Cancer :
Byrd, Victoria; Getz, Ted M; Padmanabhan, Roshan et al. (2017) Microbiome in PTEN hamartoma tumor syndrome. Endocr Relat Cancer :
Tomsic, Jerneja; Fultz, Rebecca; Liyanarachchi, Sandya et al. (2017) Variants in microRNA genes in familial papillary thyroid carcinoma. Oncotarget 8:6475-6482
Ni, Ying; Seballos, Spencer; Fletcher, Benjamin et al. (2017) Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma. Hum Mol Genet 26:243-257
Ashtekar, Amruta; Huk, Danielle; Magner, Alexa et al. (2017) Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype. Endocr Relat Cancer 24:579-591

Showing the most recent 10 out of 122 publications